XML 28 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Transactions with BioXcel LLC
3 Months Ended
Mar. 31, 2023
Transactions with BioXcel LLC  
Transactions with BioXcel LLC

Note 7. Transactions with BioXcel LLC

The Company entered into a Separation and Shared Services Agreement with BioXcel LLC that took effect on June 30, 2017, as amended and restated thereafter (the “Services Agreement”), pursuant to which BioXcel LLC has agreed to provide the Company with certain services through its subsidiaries in India and the U.S., as agreed upon by the parties. These services are primarily for drug discovery, chemical, manufacturing and controls and administrative support.

Service charges recorded under the Services Agreement for the three months ended March 31, 2023 and 2022 were as follows:

Three Months Ended March 31, 

2023

2022

Research and development

    

$

215

$

306

Selling, general and administrative

 

26

70

Total

$

241

$

376

As of March 31, 2023, $273 of service charges related to the Services Agreement are included in Due to related parties in the Company’s Condensed Consolidated Balance Sheets.